The development of a whole-cell based medium throughput screening system for the discovery of human aldosterone synthase (CYP11B2) inhibitors: Old drugs disclose new applications for the therapy of congestive heart failure, myocardial fibrosis and hypertension

Tarek Hakki1, Katja Hübel2, Herbert Waldmann2, Rita Bernhardt1
1Institute of Biochemistry, P.O. Box 151150, Saarland University, D-66041 Saarbrücken, Germany
2Max Planck Institute of Molecular Physiology, Otto-Hahn-Str, 11, D-44227 Dortmund, Germany

Tài liệu tham khảo

Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators, N. Engl. J. Med., 341, 709, 10.1056/NEJM199909023411001 Pitt, 2001, The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone post-ami heart failure efficacy and survival study, Cardiovasc. Drugs Ther., 15, 79, 10.1023/A:1011119003788 Brilla, 2000, Aldosterone and myocardial fibrosis in heart failure, Herz, 25, 299, 10.1007/s000590050024 Hakki, 2006, CYP17- and CYP11B-dependent steroid hydroxylases as drug development targets, Pharmacol. Ther., 111, 27, 10.1016/j.pharmthera.2005.07.006 Stowasser, 2001, Familial hyperaldosteronism, J. Steroid Biochem. Mol. Biol., 78, 215, 10.1016/S0960-0760(01)00097-8 Denner, 1995, Cloning and stable expression of the human mitochondrial cytochrome P45011B1 cDNA in V79 Chinese hamster cells and their application for testing of potential inhibitors, Pharmacogenetics, 5, 89, 10.1097/00008571-199504000-00005 Bureik, 2004, Development of test systems for the discovery of selective human aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) inhibitors. Discovery of a new lead compound for the therapy of congestive heart failure, myocardial fibrosis and hypertension, Mol. Cell Endocrinol., 217, 249, 10.1016/j.mce.2003.10.027 Ehmer, 2002, Development of a test system for inhibitors of human aldosterone synthase (CYP11B2): screening in fission yeast and evaluation of selectivity in V79 cells, J. Steroid Biochem. Mol. Biol., 81, 173, 10.1016/S0960-0760(02)00056-0 Ulmschneider, 2005, Synthesis and evaluation of (pyridylmethylene)tetrahydronaphthalenes/-indanes and structurally modified derivatives: potent and selective inhibitors of aldosterone synthase, J. Med. Chem., 48, 1563, 10.1021/jm0492397 Ulmschneider, 2005, Synthesis and evaluation of imidazolylmethylenetetrahydronaphthalenes and imidazolylmethyleneindanes: potent inhibitors of aldosterone synthase, J. Med. Chem., 48, 1796, 10.1021/jm049600p Baston, 2007, Inhibitors of steroidal cytochrome p450 enzymes as targets for drug development, Recent Patents Anticancer Drug Discov., 2, 31, 10.2174/157489207779561453 Schuster, 2007, Inhibition of cytochromes p450: existing and new promising therapeutic targets, Drug Metab. Rev., 39, 481, 10.1080/03602530701498455 Kawamoto, 1990, Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism, Biochem. Biophys. Res. Commun., 173, 309, 10.1016/S0006-291X(05)81058-7 Curnow, 1991, The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex, Mol. Endocrinol., 5, 1513, 10.1210/mend-5-10-1513 Denner, 1995, Cloning of CYP11B1 and CYP11B2 from normal human adrenal and their functional expression in COS-7 and V79 Chinese hamster cells, Endocrine Res., 21, 443, 10.3109/07435809509030460 Fisher, 2001, Effects of 18-hydroxylated steroids on corticosteroid production by human aldosterone synthase and 11beta-hydroxylase, J. Clin. Endocrinol. Metab., 86, 4326 Bureik, 2002, Functional expression of human mitochondrial CYP11B2 in fission yeast and identification of a new internal electron transfer protein, etp1, Biochemistry, 41, 2311, 10.1021/bi0157870 Ehmer, 2000, Development of a simple and rapid assay for the evaluation of inhibitors of human 17alpha-hydroxylase-C(17,20)-lyase (P450cl7) by coexpression of P450cl7 with NADPH-cytochrome-P450-reductase in Escherichia coli, J. Steroid Biochem. Mol. Biol., 75, 57, 10.1016/S0960-0760(00)00137-0 Dragan, 2005, Efficient conversion of 11-deoxycortisol to cortisol (hydrocortisone) by recombinant fission yeast Schizosaccharomyces pombe, FEMS Yeast Res., 5, 621, 10.1016/j.femsyr.2004.12.001 Moreno, 1991, Molecular genetic analysis of fission yeast Schizosaccharomyces pombe, Methods Enzymol., 194, 795, 10.1016/0076-6879(91)94059-L Bureik, 2000 Hakki, 2008, Coexpression of redox partners increases the hydrocortisone (cortisol) production efficiency in CYP11B1 expressing fission yeast Schizosaccharomyces pombe, J. Biotechnol., 133, 351, 10.1016/j.jbiotec.2007.06.022 Zhang, 1999, A simple statistical parameter for use in evaluation and validation of high throughput screening assays, J. Biomol. Screen., 4, 67, 10.1177/108705719900400206 Wiseman, 1996, A review of its pharmacological properties and clinical efficacy in the treatment of postmenopausal breast cancer, Drugs Aging, 9, 292, 10.2165/00002512-199609040-00006 Coombes, 1992, 4-hydroxyandrostenedione: a new treatment for postmenopausal patients with breast cancer, Eur. J. Cancer, 28A, 1941, 10.1016/0959-8049(92)90232-Q Hoffken, 1990, Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II study, J. Clin. Oncol., 8, 875, 10.1200/JCO.1990.8.5.875 Ohnaka, 2007, Hormone replacement up-to-date. Adrenopause and DHEA replacement therapy, Clin. Calcium, 17, 1334 Aimova, 2005, Antitumor drug ellipticine inhibits the activities of rat hepatic cytochromes P450, Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., 149, 437, 10.5507/bp.2005.076 Auclair, 1987, Multimodal action of antitumor agents on DNA: the ellipticine series, Arch. Biochem. Biophys., 259, 1, 10.1016/0003-9861(87)90463-2 Furst, 1959, Therapeutic re-orientation in some depressive states: clinical evaluation of a new mono-amine oxidase inhibitor (W-1554-A, phenelzine Nardil), Am. J. Psychiatry, 116, 429, 10.1176/ajp.116.5.429 Henry, 1992, Suicide and fatal antidepressant poisoning, Eur. J. Med., 1, 343 Ciocatto, 1972, Clinical features and treatment of overdosage of monoamine oxidase inhibitors and their interaction with other psychotropic drugs, Resuscitation, 1, 69, 10.1016/0300-9572(72)90066-4 Bhugra, 1986, Phenelzine induced grand mal seizure, Br. J. Clin. Pract., 40, 173, 10.1111/j.1742-1241.1986.tb07945.x Breheny, 1986, Phenelzine poisoning, Anaesthesia, 41, 53, 10.1111/j.1365-2044.1986.tb12704.x Linden, 1984, Monoamine oxidase inhibitor overdose, Ann. Emerg. Med., 13, 1137, 10.1016/S0196-0644(84)80339-X Munjack, 1984, The treatment of phenelzine-induced hypotension with salt tablets: case report, J. Clin. Psychiatry, 45, 89 Waring, 2007, Acute myocarditis after massive phenelzine overdose, Eur. J. Clin. Pharmacol., 63, 1007, 10.1007/s00228-007-0360-y